Skip to main content
. 2021 Apr 13;11:628456. doi: 10.3389/fonc.2021.628456

Figure 1.

Figure 1

Frequency of somatic mutations and predicted neoantigens in 3NSCLC patients. (A) WES and RNA-seq were performed in 3 patients with NSCLC. Tumor-specific non-synonymous somatic mutations were identified. The frequency of somatic mutations of each patient is shown. (B) Neoantigen prediction was performed for each patient. The frequency of neoantigens as well as strong binder (%rank <0.5) and weak binder (0.5< %rank <2) of each patient is shown.